Several groups have attempted to measure uPA (also known as the PLAU gene) and PAI-1 (also known as SERPINE1) mRNAs in cancer through quantitative reverse transcription-polymerase chain reaction (qRT-PCR) [35,36] and nucleic acid sequence-based amplification (NASBA) assays [37]. This evidence concerns the gene PLAU and cancer.